SDS

Conditions to avoid
no data available
Incompatible materials
Acids
Hazardous d
ecomposition
products
No decompo
sition products expected under normal conditions of use.
SECTION 11: TOXICOLOGICAL INFORMATION
Exposure routes
Eye contact, Ingestion, Inh
alation, Skin Absorption
Immediate Effects
Eye
Moderate eye irritation.
Skin
Harmful if absorbed through skin.
Ingestion
Harmful if swallowed.
Inhalation
Harmful if inhaled.
Information
on toxicological effe
cts
Acute oral toxicity
LD5
0 (male/female combi
ned rat) > 2,000 mg/kg
Acute inhalation toxicity
LC50 (male/female combi
ned rat) > 1.2 mg/l
Exposure time: 4 h
Highest attainable concentration.
Determined in the form of a respirable aerosol.
(actual)
LC5
0 (male/female combi
ned rat) > 4.8 mg/l
Exposure time: 1 h
Determined in the form of a respirable aerosol.
Extrapolated from the 4 hr LC50.
(actual)
Acute dermal toxicity
LD5
0 (male/female combi
ned rat) > 4,000 mg/kg
Skin irritation
No skin irritation (rabbit)
Eye irritation
No eye irritation (rabbit)
Sensitisation
Non
-sens
itizing. (guinea pig)
Assessment repeated dose toxicity
The toxic effects of beta-Cyfluthrin are related to tran
sient hyperactivity ty
pical for pyrethroid
neurotoxicity.
Imidacloprid did not cause specific target organ toxicity in experimental animal studies.
Assessment Mutagenicity
beta-Cyfluthrin was not mutagenic or ge
notoxic in a battery of in vitro and in vivo
tests.
Imidacloprid was not mutagenic or genotoxic based on the overall weight of evidence in a battery of in
vitro and in vivo tests.
Assessment Carcinogenicity
SBM LIFE SCIENCE CORP.
SAFETY DATA SHEET
BIOADVANCED SCIENCE-BASED
SOLUTIONS COMPLETE BRAND INSECT
KILLER FOR SOIL & TURF READY-TO-
SPREAD GRANULES
Version 1.0 / USA
102000011911
6/10
Revision Date: 01/22/2019